Releases - Biotage

View:

2003

 

Found press releases

 

EMPLOYEE STOCK OPTIONS IN BIOTAGE

12/23/2003 3:13 AM EST
December, 23 2003

Biotage AB ("Biotage") (Stockholm Stock Exchange: BIOT) announces the following.
At the Annual General Meeting of shareholders held on April 22, 2002, it was decided that a global employee stock option program would be established for the employees of the group. The Board has on December 22, 2003 resolved to allocate 550,200 employee stock options to 254 persons in accordance with...

PYROSEQUENCING FINALIZES ACQUISITION OF BIOTAGE

10/30/2003 4:45 AM EST
Uppsala, Sweden October 30, 2003 - Pyrosequencing AB (Stockholm: PYROA) today announced that the Company has finalized the acquisition of Biotage, as announced on October 14, through a cash payment of 235 MSEK and taking over a mortgage of 36 MSEK, relating to the premises in Virginia US. Pyrosequencing now owns 100 percent of the shares in Biotage.

Pyrosequencing now has a turnover of 427 MSEK, pro...

NEW MANAGEMENT AND NEW NAME FOR PYROSEQUENCING

10/23/2003 8:15 AM EST
Uppsala, Sweden, October 23, 2003 - Pyrosequencing AB (Stockholm: PYRO A) announces that in connection with the acquisition of Biotage the Company will get a new organization and a new management team. The Board also proposes that Pyrosequencing will change its name to Biotage, but will keep the logotype used since the start of the company. The name change is conditional upon the approval from an extra shareholder's...

DECISION ON NEW SHARE ISSUE

10/23/2003 7:42 AM EST
Uppsala, Sweden, October 23, 2003 - Pyrosequencing AB ("Pyrosequencing") (Stockholm: PYRO A) announces that the Board of Pyrosequencing today decided on, based on the authorization from the extraordinary general meeting on September 25, 2003, a non-cash issue of a maximum of 56,613 ordinary shares and an issue of debentures together with a maximum of 52,238 warrants for subscription of a maximum of 52,238 new...

PYROSEQUENCING ACQUIRES US BIOTAGE

10/14/2003 8:51 AM EST
Uppsala Sweden 14 October 2003 - Pyrosequencing AB (Stockholm PYROA) announces that the Company has entered into an agreement with Dyax Corp. ("Dyax") to acquire Biotage LLC ("Biotage"), a wholly-owned subsidiary of Dyax for approximately $ 35 million in cash. The Company plans to take over mortgage on Biotage's newly built premises in Virginia, which will reduce the purchase price to approximately $ 30 million....

PYROSEQUENCING IMPLEMENTS NEW ORGANIZATION

9/29/2003 5:30 AM EST
Uppsala, Sweden September 29, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced that, following the approval of the extraordinary shareholders' meeting of the acquisition of Personal Chemistry, the company will now start to implement a cost-savings program that is expected to generate annual cost synergies in the order of SEK 45-55 million. The first step is a new corporate structure, effective from...

NEW PRESIDENT AND MANAGEMENT TEAM AT PYROSEQUENCING

8/27/2003 8:30 AM EST
Uppsala, August 27, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced the appointment of the new management team for the new Company in connection with the completion of the merger with Personal Chemistry in Uppsala AB, "Personal Chemistry". The merger is planned to take place after the extraordinary general meeting on September 25, 2003. Jeff Bork continues as Chairman of the Board and CEO. Hans...

Extraordinary General Meeting in Pyrosequencing Regarding the Acquisition of Per...

8/22/2003 8:25 AM EST
Uppsala, Sweden, August 22, 2003
As announced on August 7, 2003, Pyrosequencing AB ("Pyrosequencing") (Stockholm: PYRO A) and the principal shareholders in Personal Chemistry in Uppsala AB ("Personal Chemistry") have reached an agreement that Pyrosequencing will acquire the principal shareholders' shares in Personal Chemistry, representing 94.1 percent of the share capital and votes in the company. As a...

454 Life Sciences Obtains Exclusive License from Pyrosequencing AB to Next Gener...

8/19/2003 6:30 AM EST
nome Applications

Branford, CT and Uppsala, Sweden - August 19, 2003 - 454 Life Sciences, an innovative developer of genome-scale sequencing technologies and a majority-owned subsidiary of CuraGen Corporation (NASDAQ: CRGN), today announced that the Company has obtained an exclusive license for sole use of sequencing by synthesis and pyrophosphate based sequencing for whole genome applications from...

PYROSEQUENCING AND THOMAS JEFFERSON UNIVERSITY TO DEVELOP APPLICATIONS FOR INFLA...

3/31/2003 7:00 AM EST
Uppsala, Sweden and Philadelphia, March 31, 2003 - Pyrosequencing AB (Stockholm: PYRO A) and Thomas Jefferson University, Philadelphia, announced today that they have entered into a sponsored research agreement to analyze genes and develop applications for inflammatory bowel disease (IBD). Thomas Jefferson University recently purchased a PSQ®HS 96A System, Pyrosequencing's high sensitivity genotyping platform, to...

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT